Financials
- Market Capitalization 60.64 M
- Employee 17
- Founded 2007
- CEO N/A
- Website www.edesabiotech.com
- Headquarter British Columbia, Canada
- FIGI BBG000R0LC72
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4207 | CING Cingulate Inc. - Common Stock | 4.64 USD | -1.49% | -4.13% | -5.69% | -24.68% | 61.60 M USD | ||
| 4210 | CRDF Cardiff Oncology, Inc. - Common Stock | 0.89 USD | -32.06% | -28.80% | -38.62% | -78.45% | 60.85 M USD | ||
| 4235 | CNTX Context Therapeutics Inc. - Common Stock | 0.63 USD | +1.61% | +5.00% | -10.00% | -18.18% | 57.88 M USD | ||
| 4240 | ELTX Elicio Therapeutics, Inc. - Common Stock | 3.05 USD | -1.93% | -12.61% | -24.88% | -69.50% | 58.21 M USD |
Frequently asked questions about Edesa Biotech, Inc. - Common Shares
What is the Edesa Biotech, Inc. - Common Shares stock price today?
The current price of Edesa Biotech, Inc. - Common Shares (EDSA) is 6.82. Over the past 24 hours, the stock has changed by +1.19%. Follow the EDSA chart for real-time price dynamics.
What is the stock ticker of Edesa Biotech, Inc. - Common Shares?
Edesa Biotech, Inc. - Common Shares trades under the ticker EDSA. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Edesa Biotech, Inc. - Common Shares stock going up?
EDSA has changed by -6.70% over the last week, +14.81% over the last month, and +212.84% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Edesa Biotech, Inc. - Common Shares net income for the last quarter?
Edesa Biotech, Inc. - Common Shares reported net income of -4.22 M for the last quarter. The previous quarter showed -2.25 M, which means net income changed by -87.68%.
How many employees does Edesa Biotech, Inc. - Common Shares have?
As of the latest available data, Edesa Biotech, Inc. - Common Shares has 17 employees. Workforce size can provide additional context about the company's scale and operations.
What is Edesa Biotech, Inc. - Common Shares EBITDA?
Edesa Biotech, Inc. - Common Shares EBITDA is -1.52 M, and its EBITDA margin is -12.08 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Edesa Biotech, Inc. - Common Shares stock?
You can buy Edesa Biotech, Inc. - Common Shares (EDSA) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Edesa Biotech, Inc. - Common Shares stock?
Investing in Edesa Biotech, Inc. - Common Shares requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the EDSA chart and related analysis on metatrader.com as part of your research.